TBXU Fees and Costs — Direxion Daily Biotech Top 5 Bull 2X ETF
Data updated: 2026-09-28
The net expense ratio is 0.97% (0.99% before fee waivers). There are no sales loads or redemption fees. In fiscal 2025 the fund paid $994 in broker commissions, 0.3654% of average net assets.
TBXU Fees and Expenses
Annual operating expenses and sales charges of TBXU. Prospectus, as of August 7, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.22% |
| Gross expense ratio | 0.99% |
| Fee waiver | −0.02% |
| Net expense ratio | 0.97% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
TBXU Costs Over Time
On $10,000 invested in TBXU, assuming 5% a year before costs, total costs come to $830 over 5 years, cutting the return by 1.40% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.97%) | $102 | $317 | $547 |
| Trading costs (broker commissions) | $38 | $119 | $206 |
| Lost growth on money paid in costs | $0 | $22 | $76 |
| Total costs | $140 | $458 | $830 |
| Value after costs | $10,360 | $11,119 | $11,933 |
| Impact on return, per year | 1.40% | 1.40% | 1.40% |
TBXU Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.3654%
- Total broker commissions: $994
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): —
- Securities lending: none during the year
TBXU Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Citibank, National Association | $482 | 48.47% |
| Barclays Bank PLC | $445 | 44.74% |
| BNP Paribas | $67 | 6.79% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.